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INTRODUCTION
Surgical	 treatment	 for	 empyema	 thoracis	 is	 well	
known	since	 the	 time	of	Hippocrates	(460-377	BC),	
who	has	 recognized	 the	disease	and	he	did	drainage	
of	the	empyema	through	the	intercostal	space	after	re-
section	of	one	rib1.	Since	the	Hippocrates	time,	2,400	
years	ago,	intercostal	drainage	still	remains	the	initial,	
widely-accepted	treatment	worldwide,	with	the	addi-
tion	of	antibiotics	from	the	middle	of	the	last	century.	
The	basic	principles	and	main	targets	in	the	treat-
ment	of	parapneumonic	effusion	and	empyema	thora-
cis	are	the	following:1,2.
a)	 treatment	 of	 underlying	 pulmonary	 parenchyma	
disease	and	sterilization	of	the	empyema	space	by	
the	use	of	antimicrobials
b)	 the	support	of	the	immune	and	nutritional	status	of	
the	patient
c)	 drainage	of	the	accumulated	inflammatory	pleural	
fluid	or	pus	from	the	pleural	space
d)	 the	obliteration	of	the	pleural	space
Surgery	is	involved	in	the	treatment	of	parapneu-
monic	effusions	and	empyemas	to	accomplish	drain-
age	 and	 obliteration	 of	 the	 pleural	 space.	 Surgical	
manipulation	 include	 intercostal	 chest	 tube	 drain-
age	 with	 or	 without	 the	 instillation	 of	 fibrinolytics	
(streptokinase,	urokinase,	deoxyribonuclease),	 trans-
thoracic	drainage	of	 the	effusion	 through	small	bore	
tubes	which	 are	 inserted	 in	 the	 appropriate	 position	
under	CT	guidance,	rib	resection	empyema	drainage,	
drainage	 via	 thoracotomy	 or	 thoracoscopy,	 lung	 de-
cortication	and	open	window	thoracostomy1-3.
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GUIDELINES ON SURGICAL TREATMENT 
OF PARAPNEUMONIC EFFUSIONS  
AND EMPYEMA THORACIS
In	the	current	era	of	«evidence	based	medicine»,	the	
basic	principles	of	treatment,	which	are	described	in	
the	 introduction,	 still	 remain	unchanged.	Two	medi-
cal	 societies,	 the	American College of Chest Physi-	 	 	 	
cians/ACCP (2000) and British Thoracic Society/BTS	 	 	 	 	 	
(2003)	have	published	guidelines	on	the	treatment	of	
parapneumonic	effusions	and	empyema	thoracis4,5.
According	 to	ACCP	 guidelines,	 all	 patients	with	
parapneumonic	effusions	and	empyema	are	classified	
in	four	categories,	according	to	established	criteria	of	
risk	for	poor	outcome	(Table	1).	ACCP	criteria	of	risk	
for	poor	outcome	are	any	parapneumonic	effusion	that	
occupies	more	than	half	of	the	hemithorax,	the	pres-
ence	of	loculations	and/or	thickening	of	parietal	pleu-
ra,	positive	Gram	stain	or	culture	of	the	pleural	fluid,	
ph	of	the	pleural	fluid	less	than	7.2	and/or	glucose	of	
the	pleural	fluid	 less	 than	60	mg/dl.	Drainage	of	 the	
parapneumonic	effusion	according	to	these	guidelines	
is	necessary	only	in	categories	3	(complicated	parap-
neumonic	effusion)	and	4	(empyema).	
Chest	 tube	drainage	 alone	was	 concluded	by	 the	
members	of	 the	ACCP	panel	 to	be	 inadequate	 treat-
ment	in	25%	to	50%	of	patients	with	high	risk	for	poor	
outcome	 parapneumonic	 effusion.	 Their	 conclusion	
was	based	on	the	reported	higher	mortality	rates	asso-
ciated	with	this	kind	of	drainage	and	the	frequent	need	
for	a	second	or	third	intervention,	when	compared	to	
chest	tube	drainage	plus	the	intrapleural	instillation	of	
fibrinolytic	agents,	thoracoscopic	drainage	and	drain-
age	through	standard	thoracotomy	incision.	The	mem-
bers	 of	 the	 panel	 have	 agreed	with	 the	 fact	 that	 in-
trapleural	instillation	of	fibrinolytics	and	drainage	by	
thoracoscopy	or	thoracotomy	are	all	acceptable	strate-
Table 1.	Categorization	of	parapneumonic	effusions	and	empyema	 thoracis	according	 to	ACCP	criteria	of	 risk	 for	poor	
outcome	(CHEST,	2000).
Anatomy of the  
pleural space
Pleural fluid 
bacteriology
Pleural fluid 
chemistry
Category Risk of 
poor  
outcome
Drainage 
procedure
Minimal,	free-flowing	
pleural	effusion
(<	10mm	in	lateral	
decubitus	chest	X-ray)
and
Gram	stain	and	
culture	results
unknown and
ph	unknown
1
Very	low No
Small	to	moderate	
free-flowing	pleural	
effusion	(>	10mm	and	
occupying	less	than	
half	of	the	hemithorax
and
Negative	cul-
ture	and	Gram	
stain and
ph	<	7,20
*(Glucose		
<	60	mg/dl)
2
Low No
Large,	free-flowing	
pleural	effusion,	oc-
cupying	more	than	half	
of	the	hemithorax	or	
loculated	effusion	or	
effusion	with	thick-
ened	parietal	pleura	on	
contrast-enhanced	CT	
scan	of	the	thorax
or
Positive	culture	
and	Gram	stain
or
ph	<	7,20
*(Glucose		
<	60	mg/dl)
3
Moderate Yes
pus - 4 High Yes
*If a blood gas analyzer is not available, pleural fluid glucose levels should be used.
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gies	for	 the	 treatment	of	high	risk	for	poor	outcome	
parapneumonic	effusions.	However	no	consensus	was	
obtained	on	which	of	the	above	mentioned	acceptable	
strategies	is	the	best	to	apply.	A	major	point	to	under-
lie	is	that	for	the	first	time	the	problem	of	parapneu-
monic	effusion	was	dealt	with	the	described	in	Table	1	
criteria	of	risk	for	poor	outcome	and	not	with	the	tra-
ditional	classification	of	empyema	thoracis	in	3	stages	
(exudative,	fibrinopurulent	and	organizing),	which	are	
presented	 in	Table	 2.	The	 use	 of	 criteria	 of	 risk for	 	
poor	outcome	to	classify	a	parapneumonic	effusion	is	
very	important,	because	an	accurate	estimation	of	the	
stage	of	the	disease	at	presentation	of	the	patient	or	at	
any	time	later	in	the	course	of	the	disease	is	difficult	
to	be	made.	Poor	outcome	of	a	complicated	parapneu-
monic	 effusion	 or	 empyema	was	 considered	 by	 the	
ACCP	experts	panel	to	be	the	prolonged toxic state of	 	 	 	
the	patient	or	the	need	for	surgical	intervention	in	the	
acute	phase	of	the	disease	or	the	chronic	impairment	
of	lung	function	(constrictive	pattern)	and	the	need	to	
proceed	with	lung	decortication	to	re-establish	normal	
lung	function.	Surgical	 intervention	was	regarded	as	
«primary»	 and	 «rescue»,	 depending	 on	 the	 decision	
to	perform	it	as	initial	maneuver	or	after	failure	of	any	
other	initial	treatment4.
Guidelines	published	by	BTS	are	presented	in	Fig-
ure	1.	According	to	these	guidelines	surgical	interven-
tion	 is	 always	a	«rescue»	procedure,	 as	 the	 thoracic	
surgeon	 is	 involved	 after	 failure	of	 the	 conservative	
treatment5.	Thoracoscopic	drainage	and	drainage	via	
thoracotomy	with	or	without	lung	decortication	were	
considered	to	be	acceptable	strategies	for	the	manage-
ment	of	the	disease.	BTS	experts	state	that	the	deci-
sion	on	which	drainage	method	should	be	selected	for	
the	management	of	each	patient	individually,	will	be	
based	on	 the	 availability	of	 instrumentation	 for	 tho-
racoscopic	 surgery,	 on	 the	 age	 and	 comorbidities	 of	
the	 patient	 and	on	 the	 preference	 of	 the	 responsible	
consultant	thoracic	surgeon.
SURGICAL TREATMENT
A)	Thoracoscopic (vATS) drainage
Thoracoscopic	drainage	has	 certain	 advantages	over	
chest	tube	or	CT	guided	single	or	multi-catheter	drain-
age	procedures.	Break-down	of	all	 the	adhesions	re-
sults	 in	 obliteration	 of	 the	 pleural	 cavity.	 Drainage	
of	 gel,	 debris	 and	 contaminated	 pleural	 fluid	 or	 pus	
is	complete.	Lavage	of	the	pleural	cavity	with	sterile	
saline	eliminates	the	concentration	of	microorganisms	
within	the	pleural	cavity	and	the	positioning	of	chest	
tubes	 under	 view	 through	 the	 camera	 is	 «strategic»	
and	consequently	effective.	Early	thoracoscopy	gives	
also	the	possibility	to	remove	the	thin	fibrous	film	that	
covers	visceral	pleura,	avoiding	that	way	lung	entrap-
ment.	The	technique	is	minimally	invasive,	resulting	in	
minimal	surgical	trauma	and	fast	patient’s	recovery6-9.	
Thoracoscopic	 drainage	 in	 simple	 cases	 and	 experi-
enced	hands	can	also	be	performed	 through	 the	one	
port	technique	(uniportal	VATS)	with	good	results.
Despite	 all	 the	 above	mentioned	 advantages,	 the	
Table 2.	The traditional classification of empyema in 3 stages (Chest Surgery Clinics of North America, 1996).	 	 	 	 	 	 	 	 	 	 	 	 	 	
Stage Pleural  
effusion characteristics
Biochemistry  
of the pleural fluid
Early	stage	-	exuda-
tive
Free-flowing	pleural	effusion	on	lateral	decubitus	chest	ra-
diography	and	absence	of	any	loculation	on	trans-thoracic	
ultraound	and	chest	CT	scan	
ph	>	7,3
Glucose	>	60mg/dl
LDH	<	500U/L
Second	stage		-	fibri-
nopurulent
Loculations	visible	on	lateral	decubitus	chest	radiography,	
trans-thoracic	ultrasound	or	chest	CT	scan	
ph	<	7,1
γλυκόζη	<	40mg/dl
LDH	>	1000U/L
Third	 stage	 -	 orga-
nizing
Trapping	and	immobilization	of	the	lung	from	a	thick,	in-
elastic	 peel.	 Pleural	 fluid	 becomes	 a	 gelatinous	material,	
that	is	impossible	to	drain	through	the	chest	tube
-
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exact	role	of	the	technique	in	the	management	of	the	
disease	is	not	well	defined	until	today.	There	are	two	
unanswered	questions:
1)	 Should	thoracoscopic	drainage	be	the	initial	thera-
peutic	maneuver	or	should	be	offered	as	«rescue»	
treatment?
2)	 Does	thoracoscopic	treatment	is	a	bridge	between	
failure	of	conservative	management	and	before	ag-
gressive	surgical	manipulation,	as	Landreneau	and	
coworkers	have	proposed	in	the	middle	of	the	past	
decade	(1996)?	(Figure	2).
We	have	evidence	from	just	one	prospective	ran-
domized	trial	(Wailt	et	al,	1997)	and	some	retrospec-
tive	 studies,	 that	 early	 thoracoscopic	drainage	could	
lead	 to	 a	 favorable	 outcome	 if	 applied	 early	 in	 the	
course	of	the	disease6,10-12.	In	these	studies,	where	early	
thoracoscopic	drainage	was	compared	with	chest	tube	
drainage	 and	 intrapleural	 instillation	 of	 fibrinolytic	
agents,	 the	common	findings	supporting	early	thora-
coscopic	drainage	were	the	shorter	hospital	stay,	 the	
shorter	time	of	chest	tube	drainage	and	administration	
of	antimicrobials	and	less	requirement	for	aggressive	
drainage	via	thoracotomy.	Early	thoracoscopic	drain-
age	was	effective	and	definitive	treatment	in	90%	of	
cases10-12.	 In	 the	 recent	 published	 systematic	 review	
(Cohrane	Review)	 from	Coote	 and	Kay	 (2005),	 the	
authors	conclude	that	early	thoracoscopy	seems	to	be	
the	most	effective	 treatment	of	parapneumonic	effu-
sions	and	empyemas.	It	is	important	however	to	point	
out	that	thoracoscopic	drainage	is	effective	before	the	
Figure 1.	British Thoracic Society guidelines for the man-	 	 	 	 	 	
agement	of	pleural	infection	(2003).
Figure 2.	Algorithm proposed by Landreneau and cowork-	 	 	 	 	
ers	for	the	management	of	empyema	thoracis	(1996).	Tho-
racoscopy	is	a	«bridge»	between	conservative	management	
and	aggressive	surgical	treatment.
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development	 of	 the	 organizing	 stage	 of	 empyema,	
where	the	thick	fibrous	peel	over	visceral	pleura	en-
traps	the	lung	and	limits	lung	expansion.	The	trapped	
lung	will	not	expand	despite	adequate	thoracoscopic	
drainage	at	this	stage2,7-9.	Indeed,	during	thoracoscop-
ic	exploration,	one’s	can	converse	 the	 thoracoscopic	
procedure	to	a	standard	thoracotomy	and	proceed	with	
lung	decortication,	if	lung	entrapment	is	detected2,9.
RIB RESECTION EMPYEMA DRAINAGE
Rib	resection	empyema	drainage	is	a	salvage	proce-
dure	in	debilitated	patients	or	in	ICU	patients,	where	
double-lumen	 ventilation	 (necessary	 for	 thoracosco-
py)	is	contraindicated	or	a	major	procedure	will	add	
significant	 risk	 for	 the	 patient.	The	 goal	 of	 the	 pro-
cedure	 is	 to	move	 the	 patient	 out	 of	 the	 toxic	 state,	
without	adding	the	risk	of	thoracotomy2,9,14.	There	are	
some	concerns to proceed with rib resection empyema	 	 	 	 	 	 	
drainage.	First	at	all	the	technique	is	suitable	only	for	
patients	who	have	a	limited	(<	500ml),	solitary	empy-
ema	space,	which	is	well	detected	on	chest	CT	scan	or	
plain	chest	radiography.	The	visceral	pleura	that	cover	
the	empyema	cavity	should	be	thick	enough	and	fixed	
well	to	surrounding	structures,	to	prevent	further	lung	
collapse	after	drainage	of	 the	cavity14.	Rib	 resection	
drainage	 offers	 complete	 clearance	 of	 the	 empyema	
cavity	from	pus,	gelatinous	material	and	debris,	while	
the	cavity	is	at	the	end	of	the	procedure	drained	with	
a	large	bore	chest	tube,	through	which	is	also	possible	
to	 daily	 irrigate	 the	 cavity	with	 sterile	 saline.	Chest	
tube	 is	 connected	 with	 underwater	 seal	 bottle.	 The	
drainage	 technique	 of	 open	 thoracostomy	 window,	
which	was	performed	in	the	past,	is	that	way	almost	
always	avoided.
Meticulous	study	of	chest	CT	scan	and	plain	films	
is	very	important	to	identify	the	appropriate	rib	to	re-
sect	 to	 enter	 the	 empyema	 cavity.	The	 rib	 to	 be	 re-
sected	should	be	the	inferior	rib	of	the	empyema	cav-
ity.	Drainage	of	the	cavity	is	accomplished	by	using	a	
small	rib	spreader	and	by	taking	special	care	to	avoid	
any	lung	injury	and	consequently	air	leak,	especially	
during	the	initial	application	of	the	rib	spreader14.
THORACOTOMY  
AND LUNG DECORTICATION
Any	 inflammatory	 process	 within	 the	 pleural	 cav-
ity	leads	within	a	few	days	in	the	formation	of	a	thin	
layer	of	fibrin	and	 red	cells	 that	covers	both	pleural	
surfaces,	 parietal	 and	 visceral.	 Within	 seven	 days	
from	 the	 initiation	 of	 the	 inflammatory	 process	 evi-
dence	of	fibroblastic	ingrowth	is	noted,	which	causes	
a	peel	to	develop	over	the	pleural	surfaces.	The	peel	
progressively	increases	in	thickness	and	neo-capillar-
ies	are	formed	and	extent	 into	 the	peel.	The	parietal	
portion	of	the	peel	is	usually	thicker	than	the	visceral	
portion	of	the	peel.	In	some	instances	the	pleural	peel	
is	 absorbed	 spontaneously.	 In	most	 of	 the	 cases	 the	
scenario	is	the	formation	of	a	thick,	inelastic	pleural	
cortex	that	limits	lung	expansion	and	leads	finally	to	
lung	entrapment	(«trapped»	lung).	However,	 the	un-
derlying	parietal	and	visceral	pleura	remain	thin	and	
this	fact	is	the	physiologic	basis	and	«philosophy»	of	
lung	 decortication.	When	 the	 peel	 covering	 the	 vis-
ceral	pleura	is	removed	by	a	«lege	artis»	decortication	
procedure,	 the	underlying	visceral	pleura	can	be	left	
largely	intact1.
Lung	decortication	is	a	well	established	procedure,	
which	 is	performed	 through	a	 thoracotomy	 incision,	
usually	via	the	6th	intercostal	rib,	with	or	without	rib	
resection.	 Rib	 resection	 to	 access	 the	 pleural	 space	
may	be	necessary	 in	 chronic	 empyemas,	 because	of	
the	shrinking	of	the	hemithorax	and	serious	narrowing	
of	 the	intercostal	spaces.	Break-down	of	any	locula-
tions	and	open	drainage	of	debris,	pus	and	gelatinous	
material	is	the	next	step.	After	complete	mobilization	
of	the	lung,	the	visceral	pleural	cortex	is	removed	and	
the	lung	re-expands.	Special	attention	has	to	be	made	
to	 avoid	 visceral	 pleura	 tears	 during	 removal	 of	 the	
peel	(decortication)	and	consequently	to	air	leak	cre-
ation.	Serious	air	leak	may	lead	to	the	development	of	
residual	pleural	space,	which	predispose	to	decortica-
tion	failure,	empyema	recurrence	and	to	the	need	for	
reintervention1,15.
The	main	complications	of	lung	decortication	are	
air	leak	from	the	lung	surface,	incomplete	lung	expan-
sion	and	recurrence	of	empyema,	suppuration	of	 the	
thoracotomy	wound,	postoperative	bleeding	and	rare-
ly	injury	of	the	phrenic	nerve.	Postoperative	bleeding	
may	be	a	serious	problem,	especially	when	the	parietal	
pleura	is	going	to	stripped-off.	Mortality	rates	with	the	
appropriate	 selection	 of	 patients	 for	 decortication	 is	
very	low	(<	2%)1,15.
Lung	decortication	is	a	major	procedure.	The	pro-
cedure	is	relatively	safe	with	the	appropriate	selection	
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of	 patients.	Any	 temptation	 to	 employ	 lung	 decorti-
cation	non-critically	should	be	avoided.	Lung	decor-
tication	is	 indicated	in	patients	without	high-risk	for	
thoracotomy	comorbidities,	who	have	multiloculated	
empyema	and	 lung	entrapment,	where	 thoracoscopy	
or	 rib	 resection	 drainage	 or	 open	window	 thoracos-
tomy	 are	 of	 limited	 value1,15.	Very	 careful	 selection	
is	mandatory	in	aged	and	debilitated	patients,	where	
simpler	drainage	procedures	will	give	satisfactory	re-
sults	without	 the	mortality	and	morbidity	associated	
with	 thoracotomy.	However,	 recovery	 is	expected	 to	
be	delayed	by	using	simple	drainage	procedures1.
Improvement	of	pulmonary	function	after	lung	de-
cortication	depends	on	the	state	of	the	underlying	pul-
monary	parenchyma	and	the	extent	of	the	underlying	
parenchymal	disease1,5.	The	situation	of	the	underlying	
lung	is	very	important,	as	complete	lung	re-expansion	
is	necessary	for	the	obliteration	of	the	pleural	space.	
Preoperative	 chest	CT	 scan	gives	 a	 lot	 important	 of	
information	 for	 the	 situation	 of	 the	 underlying	 lung	
parenchyma	and	it	is	an	important	examination	to	be	
done	 before	 the	 decision	 to	 proceed	with	 decortica-
tion.	It	should	be	stated	at	this	point	that	a	restrictive	
pattern	of	some	degree	is	expected	after	decortication,	
because	diaphragmatic	and	chest	wall	function	never	
will	reach	normal,	because	of	the	loss	of	their	elastic-
ity.	For	 this	 reason,	 stripping-off	 the	 thickening	 and	
inelastic	parietal	pleura	is	not	so	important	to	be	done	
and	should	be	avoided,	as	stripping	of	parietal	pleura	
may	result	in	serious	bleeding.
Lung	 decortication	 performed	 with	 the	 proper	
indications	results	in	serious	improvement	of	the	re-
spiratory	 function.	 In	 two	 published	 series,	 serious	
increase	of	FEV
1
	and	FVC	values,	percent	of	the	pre-
dicted	FEV
1
	and	FVC,	oxygen	saturation	of	the	arte-
rial	blood	and	perfusion	of	the	decorticated	lung	were	
well	detected	after	lung	decortication16,17.
COMMENTS
The	 management	 of	 parapneumonic	 effusions	 and	
empyemas	 still	 remain	 a	 point	 of	 debate	 and	 heavy	
disagreement.	Disagreement	concerning	the	use	of	in-
trapleural	 instillation	of	fibrinolytics	still	exists.	The	
results	 of	 three	 published	 prospective	 randomized	
trials	 are	 confusing	 regarding	 figures	 of	 mortality	
rate,	 time	 of	 hospitalization	 and	 the	 need	 for	 surgi-
cal	 intervention20-22.	 It	 is	well	 recognized	from	these	
series	that	the	intrapleural	instillation	of	fibrinolytics	
increases	the	amount	of	fluid	drained	from	chest	tubes	
and	improves	the	radiographic	image.	However,	in	the	
larger	 of	 these	 studies	 (Maskell	 et	 al,	 2005)	no	 cer-
tain	clinical	benefit	was	detected22.	The	authors	of	the	
above	mentioned	 study	 conclude	 that	 increasing	 the	
amount	of	drained	pleural	fluid	has	little	importance	
in	 the	era	of	modern	antibiotics22.	 In	 the	other	hand,	
the	study	has	received	heavy	criticism	from	the	sup-
porters	of	the	use	of	intapleural	instillation	of	fibrino-
lytics	through	multiple	letters23-26.
Εarly	 thoracoscopic	drainage	 tend	 to	become	 the	
standard	initial	procedure	in	high	risk	for	poor	outcome	
parpaneumonic	effusions	according	to	the	ACCP	cri-
teria,	because	of	the	doubtful	benefit	from	intrapleural	
instillation	of	fibrinolytics	and	the	high	failure	rate	of	
conservative	 therapy	 by	 chest	 tube	 drainage	 alone.	
Enthusiasm	for	early	thoracoscopic	drainage	of	com-
plicated	 parapneumonic	 effusions	 is	 supported	 from	
one	randomized	trial	(Wait	et	al,	1997)	and	some	large	
retrospective	 studies8,10-12,27.	The	 growing	 experience	
of	thoracic	surgeons	to	perform	thoracoscopy	within	
a	pleural	cavity	with	inflammatory	conditions	and	full	
of	adhesions as	in	empyema	and	complicated	parap-
neumonic	effusion,	will	further	enhance	its	use	as	ini-
tial	 therapeutic	maneuver.	The	 role	of	 thoracoscopic	
drainage	 as	 «salvage»	 treatment	 after	 failure	 of	 the	
conservative	 treatment	 is	 an	 established	 knowledge	
that	is	included	in	the	recent	published	guidelines.	
The	exact	time	to	proceed	with	surgical	interven-
tion	 in	 complicated	 parapneumonic	 effusions	 and	
empyemas	 is	not	well	defined	until	 today.	However,	
it	is	well	recognized	that	poor	outcome	is	connected	
with	 prolonged	 conservative	 treatment	 and	 delay	 to	
refer	 the	patient	 for	consultation	 to	 the	 thoracic	sur-
geon2,4,8,9,18,19,28.	Any	delay	to	refer	to	the	thoracic	sur-
geon	the	patient	who	did	not	respond	to	conservative	
treatment	 has	 as	 result	 prolong	 hospitalization	 and	
increase	 rate	 of	 need	 for	major	 surgery,	 as	 is	 drain-
age	through	thoracotomy	with	or	without	lung	decor-
tication9.	A	week	of	conservative	treatment	with	chest	
tube	drainage	and	the	appropriate	antibiotics	is	enough	
time	 to	 judge	 if	 should	 continue	 with	 conservative	
treatment	or	proceed	with	surgical	intervention2,5,29.
Moreover,	at	 the	moment	 it	 is	 impossible	 to	pre-
dict	with	certainty	who	is	the	patient	who	will	benefit	
from	conservative	management	 or	 from	early	 surgi-
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cal	 intervention2.	Early	thoracoscopic	intervention	is	
an	attractive	method	to	manage	patients	with	compli-
cated	parapneumonic	 effusions	 and	 empyemas	 from	
experienced	 in	 thoracoscopy	thoracic	surgeons30	and	
future	well	conducted	prospective	randomized	studies	
are	awaited	to	establish	the	technique	as	initial	thera-
peutic	maneuver	in	these	patients.	One’s	should	how-
ever	keep	in	mind	that	the	conduction	of	randomized	
studies	concerning	a	surgical	 technique	 is	extremely	
difficult	to	be	made,	if	not	impossible.
Thoracotomy	and	lung	decortication	is	the	appro-
priate	management	for	patients	with	lung	entrapment	
in	 the	organizing	stage	of	empyema.	Strict	selection	
of	patients	who	will	undergo	decortication	should	be	
made	to	achieve	good	results.	Thoracoscopic	decorti-
cation	is	recently	reported	in	some	small	retrospective	
studies31,32.	However,	 experience	with	 the	 procedure	
is	 at	 the	moment	 limited	 and	 the	 conversion	 rate	 to	
standard	thoracotomy	is	high	(40%)31.	Thoracoscopic	
decortication	 is	at	 the	moment	 inferior	 to	 the	decor-
tication	performed	through	the	standard	thoracotomy	
incision	for	the	management	of	organizing	empyema	
associated	with	trapped	lung29.
CONCLUSIONS
The	intrapleural	instillation	of	fibrinolytics	in	high	risk	
for	 poor	 outcome	parapneumonic	 effusions	 is	 under	
serious	concern.	Failure	of	the	conservative	treatment	
with	chest	tube	drainage	and	antibiotics	for	a	reason-
able	period	up	to	one	week	should	alert	the	physician	
to	 refer	 the	 patient	 for	 consultation	 from	 a	 thoracic	
surgeon.	Any	delay	 to	offer	surgical	 intervention	re-
sults	in	prolonged	hospitalization	and	increasing	need	
for	 major	 surgery.	 The	 exact	 role	 of	 thoracoscopic	
drainage,	 as	 initial	 therapeutic	maneuver	or	 as	 «sal-
vage»	therapy	after	failure	of	the	initial	conservative	
management,	in	high	risk	for	poor	outcome	parapneu-
monic	effusions	is	not	well	clarified	until	today.	De-
cortication	 through	 a	 standard	 thoracotomy	 incision	
is	the	procedure	of	choice	for	good	risk	patients	with	
trapped	lung	and	underlying	lung	parenchyma	not	se-
riously	involved	from	a	chronic	disease.	Stripping	of	
the	parietal	pleura	during	surgery	for	empyema	do	not	
offer	major	benefit	and	should	be	avoided.
ΠΕΡΙΛΗΨΗ:	Η	χειρουργική	θεραπεία	των	επιπλεγμένων	παραπνευμονικών	συλλογών	και	του	εμπυήματος	θώρακα	απο-
σκοπεί	στην	επαρκή	παροχέτευση	της	υπεζωκοτικής	κοιλότητας	και	την	εξάλειψη	της	κοιλότητας	του	εμπυήματος.	Δύο	
Επιστημονικές	Εταιρείες	έχουν	δημοσιεύσει	κατευθυντήριες	οδηγίες.	Το	American	College	of	Chest	Physicians	όρισε	κριτήρια	
κινδύνου	για	κακή	έκβαση.	Οι	παραπνευμονικές	συλλογές	που	πληρούν	τα	κριτήρια	αυτά	χρήζουν	παροχέτευσης	με	σωλήνα,	
η	οποία	όμως	κρίθηκε	ανεπαρκής	στο	25-50%	των	περιπτώσεων.	Ενδοπλεύρια	έγχυση	ινωδολυτικών,	θωρακοσκοπική	πα-
ροχέτευση	και	θωρακοτομή	θεωρήθηκαν	αποδεκτές	στρατηγικές,	αλλά	δεν	υπήρξε	ομοφωνία.	Στις	κατευθυντήριες	οδηγίες	
της	British	Thoracic	Society	(2003)	η	χειρουργική	εφαρμόζεται	μετά	την	αποτυχία	των	αντιβιοτικών	και	της	παροχέτευσης	
με	σωλήνα	να	ελέγξουν	τη	νόσο.
Υπάρχουν	σήμερα	ενδείξεις	που	υποστηρίζουν	ότι	η	πρώιμη	εφαρμογή	της	θωρακοσκόπησης	μειώνει	το	χρόνο	νοσηλείας,	το	
χρόνο	παραμονής	του	θωρακικού	σωλήνα	και	αποτελεί	οριστική	αρχική	αντιμετώπιση	στο	90%	των	περιπτώσεων.	Ο	ρόλος	
της	θωρακοσκόπησης	συνίσταται	σε	διάλυση	των	εγκυστώσεων,	ενοποίηση	της	υπεζωκοτικής	κοιλότητας,	παροχέτευση	
της	γέλης	και	του	φλεγμονώδους	υγρού	και	«στρατηγική»	τοποθέτηση	των	σωλήνων	παροχέτευσης.	Η	θωρακοσκόπηση	
είναι	αναποτελεσματική	στο	εμπύημα	που	βρίσκεται	στο	στάδιο	της	οργάνωσης,	όπου	η	ενδεδειγμένη	επέμβαση	είναι	η	
αποφλοίωση.	Γρήγορη	εμπλοκή	του	θωρακοχειρουργού	και	πρώιμη	εφαρμογή	θωρακοσκόπησης	μπορεί	να	αλλάξουν	την	
πρόγνωση	της	επιπλεγμένης	παραπνευμονικής	συλλογής	και	του	εμπυήματος	θώρακα.
Λέξεις Κλειδιά: Παραπνευμονική συλλογή, Επιπλεγμένη παραπνευμονική συλλογή, Εμπύημα θώρακα, Θωρακοσκόπηση, 
Αποφλοίωση πνεύμονα.
Σύγχρονες απόψεις στη χειρουργική αντιμετώπιση των παραπνευμονικών  
συλλόγων και του εμπυήματος θώρακα.
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